Clostridiumdifficile infection spreads easily and is a frequent cause of death among hospitalized older adults.

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company") is a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

At a New Jersey hospital, treating 29 patients with multiple recurrent CDI cases resulted in a net loss of more than $2.2 ...

Acurx (ACXP) announced receipt of a favorable opinion from the Paediatric Committee of the European Medicines Agency, or EMA, on Acurx’s Pediatric Investigation Plan for ibezapolstat use in children ...

The post New antibiotic beats deadly superbug in trials appeared first on Talker. A new antibiotic to fight the deadly " superbug " C. diff has proved effective in clinical trials. Treating patients ...

Your gut microbiome is comprised of the microscopic life in your digestive tract and all the things they produce. Some ...

Vitamin D significantly affects IBD by influencing severity, inflammation, and patient outcomes. Optimizing vitamin D levels ...

Chances are you see pills, powders, drinks and yogurt infused with probiotics every time you go to the grocery store. Marketed as “friendly” bacteria that aid digestion, do these products provide true ...

Less than a month after Lincoln County sold Pine Crest nursing home to a private company, state regulators cited the facility ...

Recurring Clostridioides difficile infections could be costing hospitals millions, an AtlantiCare Regional Medical Center study found. The study, published Sept. 29 in Cambridge Core, included 29 ...

Significant challenges stand in the way of the use of fecal microbiota transplantation for C difficile infection in the US, ...